The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: A retrospective analysis of a contemporary series

Ítems similars

• The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: A retrospective analysis of a contemporary series
  per: M. Marchioni, et al.
  Publicat: (2020-07-01)
• Performance of a new risk assessment tool for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the targeted therapy era: REMARCC score
  per: M.C. Mir Maresma, et al.
  Publicat: (2020-07-01)
• Minimally invasive versus open cytoreductive nephrectomy for primary metastatic renal cancer: A multi-institutional experience from the REMARCC registry
  per: R. Campi, et al.
  Publicat: (2020-07-01)
• Predictors for perioperative complications in cytoreductive nephrectomy: Analysis of the registry for metastatic RCC (REMARCC)
  per: E. Roussel, et al.
  Publicat: (2020-07-01)
• Proposal for a two-tier re-classification of stage IV/M1 renal cell carcinoma into M1 (oligometastatic) and M2 (polymetastatic) sub stages
  per: M.F. Meagher, et al.
  Publicat: (2020-07-01)